SNDL Inc. (SNDL)
NASDAQ: SNDLHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SNDL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $285.20M
- Forward P/E
- 39.00
- EPS (TTM)
- -$0.17
- Dividend yield
- None
- 52-week range
- 1.13 – 2.34
- Day range
- 1.16 – 1.26
- Volume / Avg
- 2.58M / 1.27M
- Beta
- —
- Shares outstanding
- 243.76M
52-week range
SNDL stock today
Shares of SNDL (SNDL) finished lower on Nov 20 at $1.17, a drop of 5.65% or $0.07 per share, versus the S&P 500's 3.70% decline. Volume was 2.0x the average at 2.58M shares, a sign of unusually heavy trading. Shares are 50.0% below their 52-week high of $2.34, set on Dec 18, 2025 and 3.5% above the 52-week low of $1.13, near the bottom of the past year's range.
SNDL is down 29.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 27.3%. SNDL has posted a net loss over the last twelve months (EPS of -$0.17), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About SNDL
Company profileSNDL Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally. It operates through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Zachary Ryan George IV
- Headquarters
- Edmonton, AB
- Employees
- 2,751
- IPO year
- 2019
- Website
- sndl.com
Analyst forecast
ForecastConsensus (2 analysts)
none
Avg. price target
$3.19+172.65%
- Strong buy 1
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 27, 2026
- EPS actual vs est.
- $-0.04 vs $-0.02
- Surprise
- -100.00%
SNDL news
All SNDL news- SNDL: 3 Key Takeaways for Long-Term InvestorsNasdaq
- Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?NasdaqCRON, ACB, CGC, SNDL
- SNDL (SNDL) Q3 2026 Earnings Call TranscriptNasdaq
- SNDL Inc. Reports Third Quarter 2026 Financial and Operational Results and Record Free Cash Flow of $20 MillionNasdaq
- SNDL Reports Third Quarter 2026 Financial and Operational ResultsGlobeNewswire
- SNDL Announces 2026 Annual and Special Shareholders Meeting Results, Select Preliminary Third Quarter Results and Capital Return InitiativesGlobeNewswire
- SNDL to Report Third Quarter 2026 Financial Results on October 27, 2026GlobeNewswire
SNDL peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TLRYTilray Brands Inc. | 1.89 | -8.70% | $279.32M | vs SNDL |
| ACBAurora Cannabis Inc. | 4.16 | -2.35% | $273.50M | vs SNDL |
| USNAUSANA Health Sciences Inc. | 12.94 | -1.67% | $239.24M | vs SNDL |
| MDWDMediWound Ltd. | 13.59 | +0.37% | $195.56M | vs SNDL |
| CGCCanopy Growth Corporation | 0.427 | -9.97% | $191.99M | vs SNDL |
| NAGENiagen Bioscience Inc. | 1.84 | -1.60% | $145.72M | vs SNDL |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 1.18 | -2.48% | $118.11M | vs SNDL |
| ISPRIspire Technology Inc. | 1.23 | -3.15% | $71.05M | vs SNDL |
Indexes, lists and sector
SNDL stock FAQ
What is SNDL's stock price today?
SNDL last traded at $1.17 as of Nov 20, 4:00 PM EST, down 5.65% on the day. Prices are delayed at least 15 minutes.
Does SNDL pay a dividend?
No. SNDL does not currently pay a regular cash dividend.
Who is SNDL's CEO?
Mr. Zachary Ryan George IV is the chief executive officer of SNDL Inc., which has about 2,751 employees.
Has SNDL ever split its stock?
Yes. The most recent SNDL stock split was a 1-for-10 split on Jul 26, 2022.
What is the SNDL 52-week high?
The 52-week high for SNDL is $2.34 and the 52-week low is $1.13. The stock is currently 50.0% below its high.